- Reaction score
- 110
This year, Samumed released a publication for SM04554 for the International Dermatology and Cosmetology Congress in Turkey. It contained their phase 2 results, however they normalized the hair count to baseline. The results look much more impressive then previously thought. Especially for those in the "optimal" population.
In my opinion, it sort of makes sense why the ITT drops first then rises. Depending on where they are on the scale, for someone over 45, it will take longer for the follicles to start repairing before you see results then it would be if someone started the drug in their 20's. Someone older hs more damage to their follicles. Hence the initial negative skew on ITT, and only positive result on the optimal population.
Here is the full release for anyone who wants to read it.
They also break down how they are expecting the drug to work.
In my opinion, it sort of makes sense why the ITT drops first then rises. Depending on where they are on the scale, for someone over 45, it will take longer for the follicles to start repairing before you see results then it would be if someone started the drug in their 20's. Someone older hs more damage to their follicles. Hence the initial negative skew on ITT, and only positive result on the optimal population.
Here is the full release for anyone who wants to read it.
They also break down how they are expecting the drug to work.
Last edited: